Marvel Biosciences Stock Flat as Investors Await New Pipeline MilestonesMarvel Biosciences’ shares stay flat at CAD 0.12, 20% below its 200‑day MA, offering a low‑entry point amid limited liquidity and mixed sector moves.MARVEL BIOSCIENCES CORPCanada AI generated Jake Connors 23/10/2026, 00:39 2 minutes to read
Marvel Biosciences Shares Drop 5% as Market Caps Fall to CAD 7 MillionMarvel Biosciences Corp. drops 5% in the latest trading session, now CAD 0.12, down 36% YTD—insights on market trends and comparable stocks.MARVEL BIOSCIENCES CORPCanada AI generated Elliot Mercer 21/10/2026, 02:38 One minute to read